Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Abbott Laboratories (ABT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
102.80 -0.36    -0.35%
23/09 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 2,546
  • Bid/Ask: 102.46 / 102.78
  • Day's Range: 101.44 - 103.60
Type:  Equity
Market:  Germany
ISIN:  US0028241000 
S/N:  850103
Abbott Labs 102.80 -0.36 -0.35%

Abbott Laboratories Company Profile

 
Read the Abbott company profile to learn more about the business and the management team. View employee data, company address and contact information.
IndustryHealth Care Equipment & Supplies
SectorHealthcare
Employees

113000

Equity Type

ORD

Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.

Contact Information

Top Executives

Name Age Since Title
Robert B. Ford 47 2008 Chairman of the Board, President & CEO
Michelle A. Kumbier 54 2018 Independent Director
Patricia P. Gonzalez 50 2021 Independent Director
Michael F. Roman 62 2021 Independent Director
John G. Stratton 60 2017 Independent Director
William A. Osborn 75 2008 Lead Independent Director
Nancy McKinstry 63 2011 Independent Director
Darren Wayne McDew 61 2019 Independent Director
Glenn F. Tilton 74 2007 Independent Director
Robert J. Alpern 71 2008 Independent Director
Daniel J. Starks 67 2017 Independent Director
Sally E. Blount 60 2011 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABT Comments

Write your thoughts about Abbott Laboratories
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Babar Ali
Babar Ali Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
trump sign 750 million deal with Abbott will go up??
Alexander Nygaard
Alexander Nygaard Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
750M deal and the company is valued at 196B... use your brain
Mihai Barbulescu
Mihai Barbulescu Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yeah! It will go up a lot! Like 2%!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email